In particular, vaccination with a DNA vaccine encoding the extracellular domain of TEM8 and Her2/neu resulted in prolonged survival after breast tumor cell challenge (233-VSGA1), while a DNA vaccine encoding TEM8 alone was ineffective (16). This evidence concerns the gene ANTXR1 and breast neoplasm.